nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—DHFR—Methotrexate—hematologic cancer	0.126	0.178	CbGbCtD
Pyrimethamine—CYP2C9—Bexarotene—hematologic cancer	0.0467	0.066	CbGbCtD
Pyrimethamine—CYP2C8—Bortezomib—hematologic cancer	0.0411	0.058	CbGbCtD
Pyrimethamine—CYP2D6—Lomustine—hematologic cancer	0.0397	0.0561	CbGbCtD
Pyrimethamine—CYP2C9—Idarubicin—hematologic cancer	0.0387	0.0547	CbGbCtD
Pyrimethamine—CYP2D6—Idarubicin—hematologic cancer	0.0354	0.05	CbGbCtD
Pyrimethamine—CYP2C8—Ifosfamide—hematologic cancer	0.0315	0.0445	CbGbCtD
Pyrimethamine—CYP2D6—Hydroxyurea—hematologic cancer	0.0301	0.0425	CbGbCtD
Pyrimethamine—CYP2C9—Bortezomib—hematologic cancer	0.0286	0.0405	CbGbCtD
Pyrimethamine—CYP2C8—Nilotinib—hematologic cancer	0.0273	0.0386	CbGbCtD
Pyrimethamine—CYP2D6—Bortezomib—hematologic cancer	0.0262	0.037	CbGbCtD
Pyrimethamine—CYP2C9—Thalidomide—hematologic cancer	0.0249	0.0353	CbGbCtD
Pyrimethamine—CYP2C9—Teniposide—hematologic cancer	0.0238	0.0336	CbGbCtD
Pyrimethamine—CYP2C9—Ifosfamide—hematologic cancer	0.022	0.031	CbGbCtD
Pyrimethamine—CYP2C9—Imatinib—hematologic cancer	0.021	0.0297	CbGbCtD
Pyrimethamine—CYP2D6—Imatinib—hematologic cancer	0.0192	0.0271	CbGbCtD
Pyrimethamine—CYP2C9—Nilotinib—hematologic cancer	0.0191	0.0269	CbGbCtD
Pyrimethamine—CYP2D6—Nilotinib—hematologic cancer	0.0174	0.0246	CbGbCtD
Pyrimethamine—CYP2D6—Vinorelbine—hematologic cancer	0.0173	0.0244	CbGbCtD
Pyrimethamine—CYP2C8—Etoposide—hematologic cancer	0.015	0.0213	CbGbCtD
Pyrimethamine—CYP2C8—Dexamethasone—hematologic cancer	0.0124	0.0175	CbGbCtD
Pyrimethamine—CYP2C9—Cisplatin—hematologic cancer	0.0107	0.0151	CbGbCtD
Pyrimethamine—CYP2D6—Vinblastine—hematologic cancer	0.0107	0.0151	CbGbCtD
Pyrimethamine—CYP2C9—Dexamethasone—hematologic cancer	0.00863	0.0122	CbGbCtD
Pyrimethamine—CYP2D6—Dexamethasone—hematologic cancer	0.00789	0.0112	CbGbCtD
Pyrimethamine—CYP2D6—Doxorubicin—hematologic cancer	0.00655	0.00925	CbGbCtD
Pyrimethamine—DHFR—hematopoietic system—hematologic cancer	0.00173	0.14	CbGeAlD
Pyrimethamine—DHFR—gonad—hematologic cancer	0.00132	0.106	CbGeAlD
Pyrimethamine—DHFR—blood—hematologic cancer	0.00115	0.0926	CbGeAlD
Pyrimethamine—DHFR—bone marrow—hematologic cancer	0.00111	0.0896	CbGeAlD
Pyrimethamine—DHFR—lung—hematologic cancer	0.00101	0.0812	CbGeAlD
Pyrimethamine—DHFR—testis—hematologic cancer	0.00095	0.0766	CbGeAlD
Pyrimethamine—CYP2C8—hematopoietic system—hematologic cancer	0.000861	0.0694	CbGeAlD
Pyrimethamine—CYP2C9—hematopoietic system—hematologic cancer	0.000765	0.0617	CbGeAlD
Pyrimethamine—DHFR—lymph node—hematologic cancer	0.000689	0.0555	CbGeAlD
Pyrimethamine—CYP2D6—hematopoietic system—hematologic cancer	0.000574	0.0463	CbGeAlD
Pyrimethamine—CYP2C8—blood—hematologic cancer	0.00057	0.046	CbGeAlD
Pyrimethamine—Erythema multiforme—Bortezomib—hematologic cancer	0.000518	0.00257	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Dasatinib—hematologic cancer	0.000518	0.00256	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Bexarotene—hematologic cancer	0.000518	0.00256	CcSEcCtD
Pyrimethamine—Vomiting—Mechlorethamine—hematologic cancer	0.000517	0.00256	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Fludarabine—hematologic cancer	0.000516	0.00255	CcSEcCtD
Pyrimethamine—Anorexia—Procarbazine—hematologic cancer	0.000514	0.00254	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Ifosfamide—hematologic cancer	0.000513	0.00254	CcSEcCtD
Pyrimethamine—Pancytopenia—Gemcitabine—hematologic cancer	0.00051	0.00253	CcSEcCtD
Pyrimethamine—CYP2C9—blood—hematologic cancer	0.000507	0.0408	CbGeAlD
Pyrimethamine—Anorexia—Dasatinib—hematologic cancer	0.000504	0.00249	CcSEcCtD
Pyrimethamine—Anorexia—Bexarotene—hematologic cancer	0.000504	0.00249	CcSEcCtD
Pyrimethamine—Anorexia—Fludarabine—hematologic cancer	0.000502	0.00249	CcSEcCtD
Pyrimethamine—Leukopenia—Vinblastine—hematologic cancer	0.000502	0.00248	CcSEcCtD
Pyrimethamine—Haematuria—Alitretinoin—hematologic cancer	0.0005	0.00247	CcSEcCtD
Pyrimethamine—Hypersensitivity—Methoxsalen—hematologic cancer	0.000494	0.00244	CcSEcCtD
Pyrimethamine—Haematuria—Ifosfamide—hematologic cancer	0.000494	0.00244	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Chlorambucil—hematologic cancer	0.000489	0.00242	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Imatinib—hematologic cancer	0.000486	0.0024	CcSEcCtD
Pyrimethamine—Decreased appetite—Busulfan—hematologic cancer	0.000483	0.00239	CcSEcCtD
Pyrimethamine—Hypersensitivity—Mercaptopurine—hematologic cancer	0.00048	0.00237	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Nilotinib—hematologic cancer	0.000478	0.00237	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Etoposide—hematologic cancer	0.000478	0.00237	CcSEcCtD
Pyrimethamine—Leukopenia—Melphalan—hematologic cancer	0.000477	0.00236	CcSEcCtD
Pyrimethamine—Anorexia—Chlorambucil—hematologic cancer	0.000476	0.00236	CcSEcCtD
Pyrimethamine—Pancytopenia—Cisplatin—hematologic cancer	0.000476	0.00235	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Imatinib—hematologic cancer	0.000475	0.00235	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Gemcitabine—hematologic cancer	0.000475	0.00235	CcSEcCtD
Pyrimethamine—Hypersensitivity—Daunorubicin—hematologic cancer	0.000473	0.00234	CcSEcCtD
Pyrimethamine—Hypersensitivity—Clofarabine—hematologic cancer	0.000473	0.00234	CcSEcCtD
Pyrimethamine—CYP2C8—testis—hematologic cancer	0.000472	0.038	CbGeAlD
Pyrimethamine—Hypersensitivity—Pentostatin—hematologic cancer	0.000471	0.00233	CcSEcCtD
Pyrimethamine—Haematuria—Mitoxantrone—hematologic cancer	0.000469	0.00232	CcSEcCtD
Pyrimethamine—Decreased appetite—Procarbazine—hematologic cancer	0.000469	0.00232	CcSEcCtD
Pyrimethamine—Erythema multiforme—Thalidomide—hematologic cancer	0.000467	0.00231	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Cladribine—hematologic cancer	0.000467	0.00231	CcSEcCtD
Pyrimethamine—Anorexia—Nilotinib—hematologic cancer	0.000465	0.0023	CcSEcCtD
Pyrimethamine—Leukopenia—Lenalidomide—hematologic cancer	0.000464	0.0023	CcSEcCtD
Pyrimethamine—Anorexia—Imatinib—hematologic cancer	0.000463	0.00229	CcSEcCtD
Pyrimethamine—Decreased appetite—Bexarotene—hematologic cancer	0.000459	0.00227	CcSEcCtD
Pyrimethamine—Decreased appetite—Dasatinib—hematologic cancer	0.000459	0.00227	CcSEcCtD
Pyrimethamine—Decreased appetite—Fludarabine—hematologic cancer	0.000458	0.00227	CcSEcCtD
Pyrimethamine—Leukopenia—Hydroxyurea—hematologic cancer	0.000458	0.00227	CcSEcCtD
Pyrimethamine—Haematuria—Gemcitabine—hematologic cancer	0.000457	0.00226	CcSEcCtD
Pyrimethamine—Anorexia—Cladribine—hematologic cancer	0.000455	0.00225	CcSEcCtD
Pyrimethamine—Hypersensitivity—Idarubicin—hematologic cancer	0.000454	0.00225	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Vinblastine—hematologic cancer	0.000448	0.00222	CcSEcCtD
Pyrimethamine—Erythema multiforme—Alitretinoin—hematologic cancer	0.000445	0.0022	CcSEcCtD
Pyrimethamine—Hypersensitivity—Teniposide—hematologic cancer	0.000442	0.00219	CcSEcCtD
Pyrimethamine—Erythema multiforme—Ifosfamide—hematologic cancer	0.00044	0.00218	CcSEcCtD
Pyrimethamine—Vomiting—Nelarabine—hematologic cancer	0.000436	0.00216	CcSEcCtD
Pyrimethamine—Anorexia—Vinblastine—hematologic cancer	0.000436	0.00216	CcSEcCtD
Pyrimethamine—Pancytopenia—Etoposide—hematologic cancer	0.000436	0.00216	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Melphalan—hematologic cancer	0.000435	0.00215	CcSEcCtD
Pyrimethamine—Decreased appetite—Chlorambucil—hematologic cancer	0.000434	0.00215	CcSEcCtD
Pyrimethamine—Leukopenia—Bortezomib—hematologic cancer	0.000427	0.00211	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Melphalan—hematologic cancer	0.000426	0.00211	CcSEcCtD
Pyrimethamine—Decreased appetite—Nilotinib—hematologic cancer	0.000425	0.0021	CcSEcCtD
Pyrimethamine—Leukopenia—Bleomycin—hematologic cancer	0.000424	0.0021	CcSEcCtD
Pyrimethamine—Decreased appetite—Imatinib—hematologic cancer	0.000422	0.00209	CcSEcCtD
Pyrimethamine—Leukopenia—Vinorelbine—hematologic cancer	0.000417	0.00206	CcSEcCtD
Pyrimethamine—Anorexia—Melphalan—hematologic cancer	0.000415	0.00205	CcSEcCtD
Pyrimethamine—Decreased appetite—Cladribine—hematologic cancer	0.000415	0.00205	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Lenalidomide—hematologic cancer	0.000414	0.00205	CcSEcCtD
Pyrimethamine—Vomiting—Mercaptopurine—hematologic cancer	0.000414	0.00205	CcSEcCtD
Pyrimethamine—Hypersensitivity—Busulfan—hematologic cancer	0.000409	0.00203	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Hydroxyurea—hematologic cancer	0.000409	0.00202	CcSEcCtD
Pyrimethamine—Vomiting—Clofarabine—hematologic cancer	0.000408	0.00202	CcSEcCtD
Pyrimethamine—Vomiting—Daunorubicin—hematologic cancer	0.000408	0.00202	CcSEcCtD
Pyrimethamine—Erythema multiforme—Gemcitabine—hematologic cancer	0.000407	0.00201	CcSEcCtD
Pyrimethamine—Vomiting—Pentostatin—hematologic cancer	0.000406	0.00201	CcSEcCtD
Pyrimethamine—Vomiting—Anagrelide—hematologic cancer	0.000406	0.00201	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Etoposide—hematologic cancer	0.000406	0.00201	CcSEcCtD
Pyrimethamine—Anorexia—Lenalidomide—hematologic cancer	0.000403	0.002	CcSEcCtD
Pyrimethamine—Leukopenia—Thiotepa—hematologic cancer	0.000398	0.00197	CcSEcCtD
Pyrimethamine—Anorexia—Hydroxyurea—hematologic cancer	0.000398	0.00197	CcSEcCtD
Pyrimethamine—Decreased appetite—Vinblastine—hematologic cancer	0.000398	0.00197	CcSEcCtD
Pyrimethamine—Hypersensitivity—Procarbazine—hematologic cancer	0.000397	0.00197	CcSEcCtD
Pyrimethamine—Vomiting—Idarubicin—hematologic cancer	0.000392	0.00194	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Bortezomib—hematologic cancer	0.000389	0.00193	CcSEcCtD
Pyrimethamine—Hypersensitivity—Bexarotene—hematologic cancer	0.000389	0.00193	CcSEcCtD
Pyrimethamine—Hypersensitivity—Dasatinib—hematologic cancer	0.000389	0.00193	CcSEcCtD
Pyrimethamine—Hypersensitivity—Fludarabine—hematologic cancer	0.000388	0.00192	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Bleomycin—hematologic cancer	0.000386	0.00191	CcSEcCtD
Pyrimethamine—Leukopenia—Thalidomide—hematologic cancer	0.000385	0.00191	CcSEcCtD
Pyrimethamine—Vomiting—Teniposide—hematologic cancer	0.000381	0.00189	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Bortezomib—hematologic cancer	0.000381	0.00189	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Vinorelbine—hematologic cancer	0.00038	0.00188	CcSEcCtD
Pyrimethamine—CYP2D6—blood—hematologic cancer	0.00038	0.0307	CbGeAlD
Pyrimethamine—Thrombocytopenia—Bleomycin—hematologic cancer	0.000378	0.00187	CcSEcCtD
Pyrimethamine—Decreased appetite—Melphalan—hematologic cancer	0.000378	0.00187	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Vinorelbine—hematologic cancer	0.000372	0.00184	CcSEcCtD
Pyrimethamine—Anorexia—Bortezomib—hematologic cancer	0.000371	0.00184	CcSEcCtD
Pyrimethamine—Leukopenia—Carmustine—hematologic cancer	0.00037	0.00183	CcSEcCtD
Pyrimethamine—Anorexia—Bleomycin—hematologic cancer	0.000368	0.00182	CcSEcCtD
Pyrimethamine—Decreased appetite—Lenalidomide—hematologic cancer	0.000368	0.00182	CcSEcCtD
Pyrimethamine—Hypersensitivity—Chlorambucil—hematologic cancer	0.000368	0.00182	CcSEcCtD
Pyrimethamine—Decreased appetite—Hydroxyurea—hematologic cancer	0.000363	0.0018	CcSEcCtD
Pyrimethamine—Anorexia—Vinorelbine—hematologic cancer	0.000362	0.00179	CcSEcCtD
Pyrimethamine—Leukopenia—Ifosfamide—hematologic cancer	0.000362	0.00179	CcSEcCtD
Pyrimethamine—Hypersensitivity—Nilotinib—hematologic cancer	0.00036	0.00178	CcSEcCtD
Pyrimethamine—Hypersensitivity—Imatinib—hematologic cancer	0.000358	0.00177	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Thiotepa—hematologic cancer	0.000356	0.00176	CcSEcCtD
Pyrimethamine—Vomiting—Busulfan—hematologic cancer	0.000353	0.00175	CcSEcCtD
Pyrimethamine—Leukopenia—Vincristine—hematologic cancer	0.000353	0.00175	CcSEcCtD
Pyrimethamine—Hypersensitivity—Cladribine—hematologic cancer	0.000352	0.00174	CcSEcCtD
Pyrimethamine—Erythema multiforme—Etoposide—hematologic cancer	0.000347	0.00172	CcSEcCtD
Pyrimethamine—Anorexia—Thiotepa—hematologic cancer	0.000346	0.00171	CcSEcCtD
Pyrimethamine—Leukopenia—Mitoxantrone—hematologic cancer	0.000344	0.0017	CcSEcCtD
Pyrimethamine—Leukopenia—Irinotecan—hematologic cancer	0.000344	0.0017	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Thalidomide—hematologic cancer	0.000344	0.0017	CcSEcCtD
Pyrimethamine—Vomiting—Procarbazine—hematologic cancer	0.000343	0.0017	CcSEcCtD
Pyrimethamine—Decreased appetite—Bortezomib—hematologic cancer	0.000339	0.00168	CcSEcCtD
Pyrimethamine—Hypersensitivity—Vinblastine—hematologic cancer	0.000337	0.00167	CcSEcCtD
Pyrimethamine—Vomiting—Dasatinib—hematologic cancer	0.000336	0.00166	CcSEcCtD
Pyrimethamine—Vomiting—Bexarotene—hematologic cancer	0.000336	0.00166	CcSEcCtD
Pyrimethamine—Decreased appetite—Bleomycin—hematologic cancer	0.000336	0.00166	CcSEcCtD
Pyrimethamine—Vomiting—Fludarabine—hematologic cancer	0.000335	0.00166	CcSEcCtD
Pyrimethamine—Leukopenia—Gemcitabine—hematologic cancer	0.000335	0.00166	CcSEcCtD
Pyrimethamine—Anorexia—Thalidomide—hematologic cancer	0.000335	0.00166	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Alitretinoin—hematologic cancer	0.000334	0.00165	CcSEcCtD
Pyrimethamine—Decreased appetite—Vinorelbine—hematologic cancer	0.000331	0.00164	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Carmustine—hematologic cancer	0.00033	0.00163	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Ifosfamide—hematologic cancer	0.00033	0.00163	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Alitretinoin—hematologic cancer	0.000327	0.00162	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Ifosfamide—hematologic cancer	0.000323	0.0016	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Vincristine—hematologic cancer	0.000322	0.00159	CcSEcCtD
Pyrimethamine—Anorexia—Carmustine—hematologic cancer	0.000322	0.00159	CcSEcCtD
Pyrimethamine—Hypersensitivity—Melphalan—hematologic cancer	0.000321	0.00159	CcSEcCtD
Pyrimethamine—Anorexia—Alitretinoin—hematologic cancer	0.000319	0.00158	CcSEcCtD
Pyrimethamine—Vomiting—Chlorambucil—hematologic cancer	0.000317	0.00157	CcSEcCtD
Pyrimethamine—Decreased appetite—Thiotepa—hematologic cancer	0.000316	0.00156	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Vincristine—hematologic cancer	0.000315	0.00156	CcSEcCtD
Pyrimethamine—Anorexia—Ifosfamide—hematologic cancer	0.000315	0.00156	CcSEcCtD
Pyrimethamine—CYP2D6—testis—hematologic cancer	0.000314	0.0254	CbGeAlD
Pyrimethamine—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000314	0.00155	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Irinotecan—hematologic cancer	0.000314	0.00155	CcSEcCtD
Pyrimethamine—Leukopenia—Cisplatin—hematologic cancer	0.000312	0.00155	CcSEcCtD
Pyrimethamine—Hypersensitivity—Lenalidomide—hematologic cancer	0.000312	0.00154	CcSEcCtD
Pyrimethamine—Vomiting—Nilotinib—hematologic cancer	0.00031	0.00154	CcSEcCtD
Pyrimethamine—Vomiting—Imatinib—hematologic cancer	0.000309	0.00153	CcSEcCtD
Pyrimethamine—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000307	0.00152	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Mitoxantrone—hematologic cancer	0.000307	0.00152	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Irinotecan—hematologic cancer	0.000307	0.00152	CcSEcCtD
Pyrimethamine—Anorexia—Vincristine—hematologic cancer	0.000307	0.00152	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000305	0.00151	CcSEcCtD
Pyrimethamine—Decreased appetite—Thalidomide—hematologic cancer	0.000305	0.00151	CcSEcCtD
Pyrimethamine—Vomiting—Cladribine—hematologic cancer	0.000303	0.0015	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Gemcitabine—hematologic cancer	0.000299	0.00148	CcSEcCtD
Pyrimethamine—Anorexia—Mitoxantrone—hematologic cancer	0.000299	0.00148	CcSEcCtD
Pyrimethamine—Anorexia—Irinotecan—hematologic cancer	0.000299	0.00148	CcSEcCtD
Pyrimethamine—Decreased appetite—Carmustine—hematologic cancer	0.000293	0.00145	CcSEcCtD
Pyrimethamine—Anorexia—Gemcitabine—hematologic cancer	0.000291	0.00144	CcSEcCtD
Pyrimethamine—Vomiting—Vinblastine—hematologic cancer	0.000291	0.00144	CcSEcCtD
Pyrimethamine—Decreased appetite—Alitretinoin—hematologic cancer	0.000291	0.00144	CcSEcCtD
Pyrimethamine—Decreased appetite—Ifosfamide—hematologic cancer	0.000287	0.00142	CcSEcCtD
Pyrimethamine—Hypersensitivity—Bortezomib—hematologic cancer	0.000287	0.00142	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Methotrexate—hematologic cancer	0.000286	0.00142	CcSEcCtD
Pyrimethamine—Leukopenia—Etoposide—hematologic cancer	0.000286	0.00142	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Cisplatin—hematologic cancer	0.000285	0.00141	CcSEcCtD
Pyrimethamine—Hypersensitivity—Bleomycin—hematologic cancer	0.000285	0.00141	CcSEcCtD
Pyrimethamine—Hypersensitivity—Vinorelbine—hematologic cancer	0.00028	0.00139	CcSEcCtD
Pyrimethamine—Decreased appetite—Vincristine—hematologic cancer	0.00028	0.00139	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Cisplatin—hematologic cancer	0.000279	0.00138	CcSEcCtD
Pyrimethamine—Vomiting—Melphalan—hematologic cancer	0.000277	0.00137	CcSEcCtD
Pyrimethamine—Decreased appetite—Irinotecan—hematologic cancer	0.000273	0.00135	CcSEcCtD
Pyrimethamine—Decreased appetite—Mitoxantrone—hematologic cancer	0.000273	0.00135	CcSEcCtD
Pyrimethamine—Anorexia—Cisplatin—hematologic cancer	0.000271	0.00134	CcSEcCtD
Pyrimethamine—Vomiting—Lenalidomide—hematologic cancer	0.000269	0.00133	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Epirubicin—hematologic cancer	0.000268	0.00133	CcSEcCtD
Pyrimethamine—Hypersensitivity—Thiotepa—hematologic cancer	0.000268	0.00132	CcSEcCtD
Pyrimethamine—Decreased appetite—Gemcitabine—hematologic cancer	0.000266	0.00131	CcSEcCtD
Pyrimethamine—Vomiting—Hydroxyurea—hematologic cancer	0.000265	0.00131	CcSEcCtD
Pyrimethamine—Pancytopenia—Methotrexate—hematologic cancer	0.000261	0.00129	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Etoposide—hematologic cancer	0.000261	0.00129	CcSEcCtD
Pyrimethamine—Hypersensitivity—Thalidomide—hematologic cancer	0.000259	0.00128	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Prednisolone—hematologic cancer	0.000257	0.00127	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Etoposide—hematologic cancer	0.000255	0.00126	CcSEcCtD
Pyrimethamine—Anorexia—Etoposide—hematologic cancer	0.000249	0.00123	CcSEcCtD
Pyrimethamine—Hypersensitivity—Carmustine—hematologic cancer	0.000249	0.00123	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Doxorubicin—hematologic cancer	0.000248	0.00123	CcSEcCtD
Pyrimethamine—Vomiting—Bortezomib—hematologic cancer	0.000248	0.00123	CcSEcCtD
Pyrimethamine—Decreased appetite—Cisplatin—hematologic cancer	0.000248	0.00123	CcSEcCtD
Pyrimethamine—Hypersensitivity—Alitretinoin—hematologic cancer	0.000246	0.00122	CcSEcCtD
Pyrimethamine—Vomiting—Bleomycin—hematologic cancer	0.000246	0.00122	CcSEcCtD
Pyrimethamine—Pancytopenia—Epirubicin—hematologic cancer	0.000244	0.00121	CcSEcCtD
Pyrimethamine—Hypersensitivity—Ifosfamide—hematologic cancer	0.000243	0.0012	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	0.000243	0.0012	CcSEcCtD
Pyrimethamine—Vomiting—Vinorelbine—hematologic cancer	0.000242	0.0012	CcSEcCtD
Pyrimethamine—Hypersensitivity—Vincristine—hematologic cancer	0.000237	0.00117	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000237	0.00117	CcSEcCtD
Pyrimethamine—Haematuria—Methotrexate—hematologic cancer	0.000234	0.00116	CcSEcCtD
Pyrimethamine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000231	0.00114	CcSEcCtD
Pyrimethamine—Hypersensitivity—Irinotecan—hematologic cancer	0.000231	0.00114	CcSEcCtD
Pyrimethamine—Vomiting—Thiotepa—hematologic cancer	0.000231	0.00114	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	0.000227	0.00113	CcSEcCtD
Pyrimethamine—Decreased appetite—Etoposide—hematologic cancer	0.000227	0.00112	CcSEcCtD
Pyrimethamine—Pancytopenia—Doxorubicin—hematologic cancer	0.000226	0.00112	CcSEcCtD
Pyrimethamine—Vomiting—Thalidomide—hematologic cancer	0.000223	0.00111	CcSEcCtD
Pyrimethamine—Haematuria—Epirubicin—hematologic cancer	0.000219	0.00108	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000215	0.00106	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Betamethasone—hematologic cancer	0.000215	0.00106	CcSEcCtD
Pyrimethamine—Vomiting—Carmustine—hematologic cancer	0.000214	0.00106	CcSEcCtD
Pyrimethamine—Vomiting—Alitretinoin—hematologic cancer	0.000212	0.00105	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.00021	0.00104	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Betamethasone—hematologic cancer	0.00021	0.00104	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Dexamethasone—hematologic cancer	0.00021	0.00104	CcSEcCtD
Pyrimethamine—Vomiting—Ifosfamide—hematologic cancer	0.00021	0.00104	CcSEcCtD
Pyrimethamine—Hypersensitivity—Cisplatin—hematologic cancer	0.00021	0.00104	CcSEcCtD
Pyrimethamine—Erythema multiforme—Methotrexate—hematologic cancer	0.000208	0.00103	CcSEcCtD
Pyrimethamine—Vomiting—Vincristine—hematologic cancer	0.000205	0.00101	CcSEcCtD
Pyrimethamine—Anorexia—Dexamethasone—hematologic cancer	0.000205	0.00101	CcSEcCtD
Pyrimethamine—Anorexia—Betamethasone—hematologic cancer	0.000205	0.00101	CcSEcCtD
Pyrimethamine—Haematuria—Doxorubicin—hematologic cancer	0.000202	0.001	CcSEcCtD
Pyrimethamine—Vomiting—Irinotecan—hematologic cancer	0.000199	0.000987	CcSEcCtD
Pyrimethamine—Vomiting—Mitoxantrone—hematologic cancer	0.000199	0.000987	CcSEcCtD
Pyrimethamine—Erythema multiforme—Epirubicin—hematologic cancer	0.000195	0.000963	CcSEcCtD
Pyrimethamine—Vomiting—Gemcitabine—hematologic cancer	0.000194	0.000961	CcSEcCtD
Pyrimethamine—Hypersensitivity—Etoposide—hematologic cancer	0.000192	0.000951	CcSEcCtD
Pyrimethamine—Hypersensitivity—Prednisolone—hematologic cancer	0.00019	0.000938	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Prednisone—hematologic cancer	0.000187	0.000925	CcSEcCtD
Pyrimethamine—Decreased appetite—Betamethasone—hematologic cancer	0.000187	0.000924	CcSEcCtD
Pyrimethamine—Decreased appetite—Dexamethasone—hematologic cancer	0.000187	0.000924	CcSEcCtD
Pyrimethamine—Vomiting—Cisplatin—hematologic cancer	0.000181	0.000896	CcSEcCtD
Pyrimethamine—Erythema multiforme—Doxorubicin—hematologic cancer	0.00018	0.000891	CcSEcCtD
Pyrimethamine—Anorexia—Prednisone—hematologic cancer	0.000178	0.000882	CcSEcCtD
Pyrimethamine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000174	0.000863	CcSEcCtD
Pyrimethamine—Leukopenia—Methotrexate—hematologic cancer	0.000171	0.000848	CcSEcCtD
Pyrimethamine—Vomiting—Etoposide—hematologic cancer	0.000166	0.000821	CcSEcCtD
Pyrimethamine—Decreased appetite—Prednisone—hematologic cancer	0.000163	0.000804	CcSEcCtD
Pyrimethamine—Leukopenia—Epirubicin—hematologic cancer	0.00016	0.000794	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Methotrexate—hematologic cancer	0.000156	0.000773	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Methotrexate—hematologic cancer	0.000153	0.000757	CcSEcCtD
Pyrimethamine—Vomiting—Triamcinolone—hematologic cancer	0.00015	0.000745	CcSEcCtD
Pyrimethamine—Anorexia—Methotrexate—hematologic cancer	0.000149	0.000737	CcSEcCtD
Pyrimethamine—Leukopenia—Doxorubicin—hematologic cancer	0.000148	0.000735	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Epirubicin—hematologic cancer	0.000146	0.000724	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Epirubicin—hematologic cancer	0.000143	0.000709	CcSEcCtD
Pyrimethamine—Anorexia—Epirubicin—hematologic cancer	0.000139	0.00069	CcSEcCtD
Pyrimethamine—Hypersensitivity—Prednisone—hematologic cancer	0.000138	0.000682	CcSEcCtD
Pyrimethamine—Vomiting—Betamethasone—hematologic cancer	0.000137	0.000676	CcSEcCtD
Pyrimethamine—Vomiting—Dexamethasone—hematologic cancer	0.000137	0.000676	CcSEcCtD
Pyrimethamine—Decreased appetite—Methotrexate—hematologic cancer	0.000136	0.000672	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000135	0.00067	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000132	0.000656	CcSEcCtD
Pyrimethamine—Anorexia—Doxorubicin—hematologic cancer	0.000129	0.000638	CcSEcCtD
Pyrimethamine—Decreased appetite—Epirubicin—hematologic cancer	0.000127	0.000629	CcSEcCtD
Pyrimethamine—Vomiting—Prednisone—hematologic cancer	0.000119	0.000588	CcSEcCtD
Pyrimethamine—Decreased appetite—Doxorubicin—hematologic cancer	0.000118	0.000582	CcSEcCtD
Pyrimethamine—Hypersensitivity—Methotrexate—hematologic cancer	0.000115	0.00057	CcSEcCtD
Pyrimethamine—Hypersensitivity—Epirubicin—hematologic cancer	0.000108	0.000533	CcSEcCtD
Pyrimethamine—Lamotrigine—ABCB1—hematologic cancer	0.000105	1	CrCbGaD
Pyrimethamine—Hypersensitivity—Doxorubicin—hematologic cancer	9.97e-05	0.000493	CcSEcCtD
Pyrimethamine—Vomiting—Methotrexate—hematologic cancer	9.93e-05	0.000492	CcSEcCtD
Pyrimethamine—Vomiting—Epirubicin—hematologic cancer	9.3e-05	0.00046	CcSEcCtD
Pyrimethamine—Vomiting—Doxorubicin—hematologic cancer	8.6e-05	0.000426	CcSEcCtD
Pyrimethamine—DHFR—Disease—PDGFRA—hematologic cancer	3.24e-05	0.000416	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HDC—hematologic cancer	3.24e-05	0.000415	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PRKCG—hematologic cancer	3.23e-05	0.000414	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—JAK1—hematologic cancer	3.23e-05	0.000414	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SMPD3—hematologic cancer	3.21e-05	0.000411	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SMPD3—hematologic cancer	3.18e-05	0.000408	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	3.17e-05	0.000407	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—MAPK3—hematologic cancer	3.1e-05	0.000397	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—EP300—hematologic cancer	3.09e-05	0.000397	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTP1—hematologic cancer	3.08e-05	0.000395	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	3.02e-05	0.000387	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—MYC—hematologic cancer	3.01e-05	0.000387	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MTHFR—hematologic cancer	2.99e-05	0.000384	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TERT—hematologic cancer	2.98e-05	0.000382	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HLA-A—hematologic cancer	2.98e-05	0.000382	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.96e-05	0.00038	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CDA—hematologic cancer	2.96e-05	0.00038	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ABCB1—hematologic cancer	2.92e-05	0.000374	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PDGFB—hematologic cancer	2.91e-05	0.000373	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.89e-05	0.00037	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PC—hematologic cancer	2.85e-05	0.000365	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TSC2—hematologic cancer	2.84e-05	0.000365	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—NCOR1—hematologic cancer	2.83e-05	0.000363	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTM1—hematologic cancer	2.83e-05	0.000363	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—B3GAT1—hematologic cancer	2.8e-05	0.000359	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ASNS—hematologic cancer	2.8e-05	0.000359	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—DCK—hematologic cancer	2.8e-05	0.000359	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—B3GAT1—hematologic cancer	2.78e-05	0.000356	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ASNS—hematologic cancer	2.78e-05	0.000356	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—DCK—hematologic cancer	2.78e-05	0.000356	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—MAPK3—hematologic cancer	2.77e-05	0.000355	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC35B2—hematologic cancer	2.75e-05	0.000353	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GBA—hematologic cancer	2.75e-05	0.000353	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—FGFR3—hematologic cancer	2.74e-05	0.000351	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.71e-05	0.000348	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—MYC—hematologic cancer	2.69e-05	0.000346	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HDC—hematologic cancer	2.66e-05	0.000341	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HDC—hematologic cancer	2.63e-05	0.000338	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—BAD—hematologic cancer	2.59e-05	0.000333	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NOTCH1—hematologic cancer	2.57e-05	0.00033	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CD80—hematologic cancer	2.52e-05	0.000323	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTAP—hematologic cancer	2.52e-05	0.000323	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—KIT—hematologic cancer	2.51e-05	0.000322	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—MTHFR—hematologic cancer	2.5e-05	0.000321	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTPN11—hematologic cancer	2.47e-05	0.000317	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.45e-05	0.000315	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CDA—hematologic cancer	2.43e-05	0.000312	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CDA—hematologic cancer	2.41e-05	0.000309	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CREB1—hematologic cancer	2.39e-05	0.000307	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—BRAF—hematologic cancer	2.36e-05	0.000303	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PC—hematologic cancer	2.34e-05	0.0003	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6R—hematologic cancer	2.33e-05	0.000299	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CREBBP—hematologic cancer	2.33e-05	0.000299	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PC—hematologic cancer	2.32e-05	0.000297	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GBA—hematologic cancer	2.26e-05	0.00029	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	2.26e-05	0.00029	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—FHL2—hematologic cancer	2.24e-05	0.000288	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GBA—hematologic cancer	2.24e-05	0.000287	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC35B2—hematologic cancer	2.24e-05	0.000287	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MAP2K1—hematologic cancer	2.22e-05	0.000285	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—TP53—hematologic cancer	2.21e-05	0.000284	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CD—hematologic cancer	2.21e-05	0.000283	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AGRN—hematologic cancer	2.2e-05	0.000282	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—FGF2—hematologic cancer	2.11e-05	0.000271	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CG—hematologic cancer	2.1e-05	0.00027	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3R1—hematologic cancer	2.08e-05	0.000267	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—IDH2—hematologic cancer	2.08e-05	0.000267	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HMMR—hematologic cancer	2.08e-05	0.000267	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTAP—hematologic cancer	2.07e-05	0.000265	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTAP—hematologic cancer	2.05e-05	0.000263	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—JAK2—hematologic cancer	2.03e-05	0.00026	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MDM2—hematologic cancer	1.98e-05	0.000254	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.97e-05	0.000252	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ARNTL—hematologic cancer	1.96e-05	0.000251	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CREBBP—hematologic cancer	1.95e-05	0.00025	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CB—hematologic cancer	1.92e-05	0.000247	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MTOR—hematologic cancer	1.92e-05	0.000247	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CD4—hematologic cancer	1.92e-05	0.000246	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ACP5—hematologic cancer	1.91e-05	0.000245	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CA9—hematologic cancer	1.91e-05	0.000245	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOR2—hematologic cancer	1.88e-05	0.000241	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CD—hematologic cancer	1.85e-05	0.000237	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—FHL2—hematologic cancer	1.84e-05	0.000236	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ALB—hematologic cancer	1.83e-05	0.000234	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—FHL2—hematologic cancer	1.82e-05	0.000234	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CDKN1B—hematologic cancer	1.81e-05	0.000232	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AGRN—hematologic cancer	1.81e-05	0.000232	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—IDH1—hematologic cancer	1.79e-05	0.00023	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AGRN—hematologic cancer	1.79e-05	0.00023	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTO1—hematologic cancer	1.77e-05	0.000227	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TXN—hematologic cancer	1.77e-05	0.000227	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCC3—hematologic cancer	1.77e-05	0.000227	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3R1—hematologic cancer	1.75e-05	0.000224	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SPHK1—hematologic cancer	1.73e-05	0.000223	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMMR—hematologic cancer	1.71e-05	0.00022	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—IDH2—hematologic cancer	1.71e-05	0.00022	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMMR—hematologic cancer	1.7e-05	0.000218	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—IDH2—hematologic cancer	1.7e-05	0.000218	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CDKN1A—hematologic cancer	1.67e-05	0.000214	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—UGT1A1—hematologic cancer	1.67e-05	0.000214	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTEN—hematologic cancer	1.66e-05	0.000213	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CRABP1—hematologic cancer	1.62e-05	0.000208	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC22A1—hematologic cancer	1.62e-05	0.000208	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CB—hematologic cancer	1.61e-05	0.000207	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.61e-05	0.000206	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.6e-05	0.000205	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.6e-05	0.000205	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EP300—hematologic cancer	1.59e-05	0.000203	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALOX5—hematologic cancer	1.58e-05	0.000203	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CA9—hematologic cancer	1.57e-05	0.000201	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ACP5—hematologic cancer	1.57e-05	0.000201	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CA9—hematologic cancer	1.55e-05	0.000199	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ACP5—hematologic cancer	1.55e-05	0.000199	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.54e-05	0.000198	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SRC—hematologic cancer	1.54e-05	0.000198	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.53e-05	0.000196	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NUP98—hematologic cancer	1.53e-05	0.000196	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—STAT3—hematologic cancer	1.49e-05	0.000191	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ADCY7—hematologic cancer	1.49e-05	0.000191	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOA3—hematologic cancer	1.49e-05	0.000191	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NRAS—hematologic cancer	1.48e-05	0.00019	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NUP214—hematologic cancer	1.47e-05	0.000189	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—IDH1—hematologic cancer	1.47e-05	0.000189	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.46e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—IDH1—hematologic cancer	1.46e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.46e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.46e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TXN—hematologic cancer	1.46e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTR—hematologic cancer	1.44e-05	0.000185	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCG2—hematologic cancer	1.44e-05	0.000185	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.44e-05	0.000185	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TXN—hematologic cancer	1.44e-05	0.000185	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.44e-05	0.000185	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.42e-05	0.000183	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MAPK3—hematologic cancer	1.42e-05	0.000182	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ENO2—hematologic cancer	1.42e-05	0.000182	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.41e-05	0.000181	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTEN—hematologic cancer	1.39e-05	0.000179	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MYC—hematologic cancer	1.38e-05	0.000177	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TGFB1—hematologic cancer	1.38e-05	0.000177	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTT1—hematologic cancer	1.37e-05	0.000176	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.37e-05	0.000176	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.36e-05	0.000174	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.35e-05	0.000174	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SDC1—hematologic cancer	1.34e-05	0.000172	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.33e-05	0.000171	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.33e-05	0.000171	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—EP300—hematologic cancer	1.33e-05	0.00017	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.32e-05	0.000169	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.32e-05	0.000169	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.3e-05	0.000166	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.29e-05	0.000165	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.28e-05	0.000165	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—KRAS—hematologic cancer	1.28e-05	0.000164	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.27e-05	0.000163	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NUP98—hematologic cancer	1.26e-05	0.000161	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NUP98—hematologic cancer	1.25e-05	0.00016	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.22e-05	0.000156	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.22e-05	0.000156	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.21e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NUP214—hematologic cancer	1.21e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ADCY7—hematologic cancer	1.21e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOA3—hematologic cancer	1.21e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NUP214—hematologic cancer	1.2e-05	0.000154	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.19e-05	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.19e-05	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTR—hematologic cancer	1.19e-05	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCG2—hematologic cancer	1.18e-05	0.000151	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTR—hematologic cancer	1.18e-05	0.000151	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CA—hematologic cancer	1.17e-05	0.000151	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ENO2—hematologic cancer	1.16e-05	0.000149	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ENO2—hematologic cancer	1.15e-05	0.000148	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CD44—hematologic cancer	1.14e-05	0.000147	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NQO1—hematologic cancer	1.14e-05	0.000147	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.13e-05	0.000145	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.12e-05	0.000144	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.12e-05	0.000143	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SDC1—hematologic cancer	1.1e-05	0.000141	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.1e-05	0.000141	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SDC1—hematologic cancer	1.09e-05	0.00014	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HRAS—hematologic cancer	1.09e-05	0.000139	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYCS—hematologic cancer	1.08e-05	0.000139	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	1.07e-05	0.000138	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.04e-05	0.000134	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6—hematologic cancer	1.04e-05	0.000133	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.03e-05	0.000132	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.86e-06	0.000127	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CA—hematologic cancer	9.83e-06	0.000126	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.66e-06	0.000124	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—AKT1—hematologic cancer	9.58e-06	0.000123	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTP1—hematologic cancer	9.53e-06	0.000122	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NQO1—hematologic cancer	9.38e-06	0.00012	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CD44—hematologic cancer	9.38e-06	0.00012	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NQO1—hematologic cancer	9.3e-06	0.000119	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CD44—hematologic cancer	9.3e-06	0.000119	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.22e-06	0.000118	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.1e-06	0.000117	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCB1—hematologic cancer	9.02e-06	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYCS—hematologic cancer	8.87e-06	0.000114	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	8.82e-06	0.000113	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYCS—hematologic cancer	8.8e-06	0.000113	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTM1—hematologic cancer	8.75e-06	0.000112	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOR1—hematologic cancer	8.75e-06	0.000112	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	8.74e-06	0.000112	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—AKT1—hematologic cancer	8.03e-06	0.000103	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.87e-06	0.000101	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTP1—hematologic cancer	7.82e-06	0.0001	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTP1—hematologic cancer	7.75e-06	9.95e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTHFR—hematologic cancer	7.74e-06	9.93e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.5e-06	9.62e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCB1—hematologic cancer	7.4e-06	9.5e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCB1—hematologic cancer	7.34e-06	9.42e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTM1—hematologic cancer	7.19e-06	9.22e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOR1—hematologic cancer	7.19e-06	9.22e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTM1—hematologic cancer	7.12e-06	9.14e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOR1—hematologic cancer	7.12e-06	9.14e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.82e-06	8.75e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	6.5e-06	8.34e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTHFR—hematologic cancer	6.35e-06	8.15e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTHFR—hematologic cancer	6.3e-06	8.08e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CREBBP—hematologic cancer	6.03e-06	7.73e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	5.71e-06	7.33e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALB—hematologic cancer	5.64e-06	7.24e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.55e-06	7.12e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	5.4e-06	6.92e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	5.34e-06	6.85e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	5.29e-06	6.79e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	4.98e-06	6.39e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CREBBP—hematologic cancer	4.95e-06	6.35e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CREBBP—hematologic cancer	4.91e-06	6.29e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	4.69e-06	6.02e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	4.65e-06	5.97e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALB—hematologic cancer	4.63e-06	5.94e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALB—hematologic cancer	4.59e-06	5.89e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	4.43e-06	5.68e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4.39e-06	5.63e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTEN—hematologic cancer	4.3e-06	5.52e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—EP300—hematologic cancer	4.1e-06	5.27e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	4.09e-06	5.25e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	4.05e-06	5.2e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTEN—hematologic cancer	3.53e-06	4.53e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTEN—hematologic cancer	3.5e-06	4.49e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—EP300—hematologic cancer	3.37e-06	4.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—EP300—hematologic cancer	3.34e-06	4.29e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	3.04e-06	3.9e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.49e-06	3.2e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AKT1—hematologic cancer	2.48e-06	3.18e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.47e-06	3.17e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKT1—hematologic cancer	2.04e-06	2.61e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKT1—hematologic cancer	2.02e-06	2.59e-05	CbGpPWpGaD
